NAVAMEDIC (NAVA.OL) Stock Price, Forecast & Analysis

OSL:NAVA • NO0010205966

21.3 NOK
-0.2 (-0.93%)
Last: Feb 17, 2026, 07:00 PM

NAVA.OL Key Statistics, Chart & Performance

Key Statistics
Market Cap510.77M
Revenue(TTM)539.42M
Net Income(TTM)-39.43M
Shares23.98M
Float15.85M
52 Week High27.9
52 Week Low17.1
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-2.21
PEN/A
Fwd PE29
Earnings (Next)N/A
IPO2006-03-31
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
NAVA.OL short term performance overview.The bars show the price performance of NAVA.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -2 -4

NAVA.OL long term performance overview.The bars show the price performance of NAVA.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of NAVA.OL is 21.3 NOK. In the past month the price decreased by -1.84%. In the past year, price decreased by -0.47%.

NAVAMEDIC / NAVA Daily stock chart

NAVA.OL Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
NAVA.OL Full Technical Analysis Report

NAVA.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to NAVA.OL. NAVA.OL has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
NAVA.OL Full Fundamental Analysis Report

NAVA.OL Financial Highlights

Over the last trailing twelve months NAVA.OL reported a non-GAAP Earnings per Share(EPS) of -2.21. The EPS decreased by -290.46% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -5.53%
ROE -18.8%
Debt/Equity 1.34
Chartmill High Growth Momentum
EPS Q2Q%-194.12%
Sales Q2Q%12.89%
EPS 1Y (TTM)-290.46%
Revenue 1Y (TTM)2.64%
NAVA.OL financials

NAVA.OL Forecast & Estimates

7 analysts have analysed NAVA.OL and the average price target is 36.72 NOK. This implies a price increase of 72.39% is expected in the next year compared to the current price of 21.3.

For the next year, analysts expect an EPS growth of -144.15% and a revenue growth 10.54% for NAVA.OL


Analysts
Analysts82.86
Price Target36.72 (72.39%)
EPS Next Y-144.15%
Revenue Next Year10.54%
NAVA.OL Analyst EstimatesNAVA.OL Analyst Ratings

NAVA.OL Ownership

Ownership
Inst Owners30.47%
Ins Owners12.02%
Short Float %N/A
Short RatioN/A
NAVA.OL Ownership

About NAVA.OL

Company Profile

NAVA logo image Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo and currently employs 42 full-time employees. The company went IPO on 2006-03-31. The company is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The firm has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The firm has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.

Company Info

NAVAMEDIC

Henrik Ibsens gate 100

Oslo OSLO NO

Employees: 45

NAVA Company Website

NAVA Investor Relations

Phone: 4767112540

NAVAMEDIC / NAVA.OL FAQ

Can you describe the business of NAVAMEDIC?

Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo and currently employs 42 full-time employees. The company went IPO on 2006-03-31. The company is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The firm has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The firm has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.


Can you provide the latest stock price for NAVAMEDIC?

The current stock price of NAVA.OL is 21.3 NOK. The price decreased by -0.93% in the last trading session.


Does NAVA stock pay dividends?

NAVA.OL does not pay a dividend.


What is the ChartMill rating of NAVAMEDIC stock?

NAVA.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


How many employees does NAVAMEDIC have?

NAVAMEDIC (NAVA.OL) currently has 45 employees.


What is NAVAMEDIC worth?

NAVAMEDIC (NAVA.OL) has a market capitalization of 510.77M NOK. This makes NAVA.OL a Small Cap stock.